214 related articles for article (PubMed ID: 22698813)
1. Median lethal dose determination for percutaneous exposure to soman and VX in guinea pigs and the effectiveness of decontamination with M291 SDK or SANDIA foam.
Clarkson ED; Schulz SM; Railer RF; Smith KH
Toxicol Lett; 2012 Aug; 212(3):282-7. PubMed ID: 22698813
[TBL] [Abstract][Full Text] [Related]
2. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
[TBL] [Abstract][Full Text] [Related]
3. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 2: guinea pigs challenged with soman.
Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
Cutan Ocul Toxicol; 2011 Mar; 30(1):29-37. PubMed ID: 20964500
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous toxicity and decontamination of soman, VX, and paraoxon in rats using detergents.
Misík J; Pavliková R; Kuča K
Arh Hig Rada Toksikol; 2013 Jun; 64(2):25-31. PubMed ID: 23819929
[TBL] [Abstract][Full Text] [Related]
5. Immediate post-dosing paralysis following severe soman and VX toxicosis in guinea pigs.
Bide RW; Schofield L; Risk DJ
J Appl Toxicol; 2005; 25(5):410-7. PubMed ID: 16092080
[TBL] [Abstract][Full Text] [Related]
6. The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure.
Joosen MJ; van den Berg RM; de Jong AL; van der Schans MJ; Noort D; Langenberg JP
Chem Biol Interact; 2017 Apr; 267():48-56. PubMed ID: 26855350
[TBL] [Abstract][Full Text] [Related]
7. Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 2: evaluation of in vitro topical decontamination efficacy using undamaged skin.
Dalton CH; Hall CA; Lydon HL; Chipman JK; Graham JS; Jenner J; Chilcott RP
J Appl Toxicol; 2015 May; 35(5):543-50. PubMed ID: 25219755
[TBL] [Abstract][Full Text] [Related]
8. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
Lydon H; Hall C; Matar H; Dalton C; Chipman JK; Graham JS; Chilcott RP
J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
[TBL] [Abstract][Full Text] [Related]
9. Determination of LCt(50)s in anesthetized rats exposed to aerosolized nerve agents.
Collins JL; Peng X; Lee R; Witriol A; Pierre Z; Sciuto AM
Toxicol Mech Methods; 2013 Feb; 23(2):127-33. PubMed ID: 22978758
[TBL] [Abstract][Full Text] [Related]
10. Further studies of the efficacy of military, commercial and novel skin decontaminants against the chemical warfare agents sulphur Mustard, Soman and VX.
Matar H; Price SC; Chilcott RP
Toxicol In Vitro; 2019 Feb; 54():263-268. PubMed ID: 30347232
[TBL] [Abstract][Full Text] [Related]
11. Comparison of selected skin decontaminant products and regimens against VX in domestic swine.
Bjarnason S; Mikler J; Hill I; Tenn C; Garrett M; Caddy N; Sawyer TW
Hum Exp Toxicol; 2008 Mar; 27(3):253-61. PubMed ID: 18650258
[TBL] [Abstract][Full Text] [Related]
12. Repeated low-dose exposures to sarin, soman, or VX affect acoustic startle in guinea pigs.
Smith CD; Lee RB; Moran AV; Sipos ML
Neurotoxicol Teratol; 2016; 54():36-45. PubMed ID: 26829110
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX.
Saxena A; Sun W; Fedorko JM; Koplovitz I; Doctor BP
Biochem Pharmacol; 2011 Jan; 81(1):164-9. PubMed ID: 20846507
[TBL] [Abstract][Full Text] [Related]
14. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
Joosen MJ; van der Schans MJ; Kuijpers WC; van Helden HP; Noort D
Chem Biol Interact; 2013 Mar; 203(1):149-53. PubMed ID: 23085122
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the decontamination efficacy of foam-making blends based on cationic and nonionic tensides against organophosphorus compounds determined in vitro and in vivo.
Cabal J; Kassa J; Severa J
Hum Exp Toxicol; 2003 Sep; 22(9):507-14. PubMed ID: 14580011
[TBL] [Abstract][Full Text] [Related]
16. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.
Hamilton MG; Hill I; Conley J; Sawyer TW; Caneva DC; Lundy PM
Mil Med; 2004 Nov; 169(11):856-62. PubMed ID: 15605929
[TBL] [Abstract][Full Text] [Related]
17. The percutaneous absorption of soman in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
Dalton C; Hall C; Lydon H; Jenner J; Chipman JK; Graham JS; Chilcott RP
Cutan Ocul Toxicol; 2018 Jun; 37(2):172-179. PubMed ID: 28853336
[TBL] [Abstract][Full Text] [Related]
18. Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin.
Thors L; Koch M; Wigenstam E; Koch B; Hägglund L; Bucht A
Chem Biol Interact; 2017 Aug; 273():82-89. PubMed ID: 28601555
[TBL] [Abstract][Full Text] [Related]
19. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration.
van der Schans MJ; Lander BJ; van der Wiel H; Langenberg JP; Benschop HP
Toxicol Appl Pharmacol; 2003 Aug; 191(1):48-62. PubMed ID: 12915103
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse (II): effects of some currently used skin decontaminants (RSDL and Fuller's earth) against liquid sulphur mustard and VX exposure.
Taysse L; Dorandeu F; Daulon S; Foquin A; Perrier N; Lallement G; Breton P
Hum Exp Toxicol; 2011 Jun; 30(6):491-8. PubMed ID: 20534641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
